TELTEXA BETA 25
| Dosage: As directed by the Registered Medical Practitioner. |
| Side-effects: Headache, Weakness, Dizziness, Cold extremities, Slow heart rate, Increased potassium level in blood, Numbness of extremity, Decreased blood pressure |
| Contraindications: Contraindicated in patients with known hypersensitivity. |
| Presentation: Available in blister pack of 15 tablets. |
Description
Teltexa Beta 25
Telmisartan 40mg + Metoprolol succinate 25mg
Description:
Teltexa Beta 25 is the combination of two blood-pressure lowering medicines: Telmisartan and Metoprolol Succinate.
Indications:
Teltexa Beta 25 is used in the treatment of Hypertension (high blood pressure).
Composition:
Teltexa Beta 25
Each film coated bilayered tablet contains :
Telmisartan IP 40mg
Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg (as extended release form)
Colours : Red oxide of Iron & Titanium dioxide IP
Excipients qs
